JP2021505554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505554A5 JP2021505554A5 JP2020529733A JP2020529733A JP2021505554A5 JP 2021505554 A5 JP2021505554 A5 JP 2021505554A5 JP 2020529733 A JP2020529733 A JP 2020529733A JP 2020529733 A JP2020529733 A JP 2020529733A JP 2021505554 A5 JP2021505554 A5 JP 2021505554A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- salt
- macular
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382832.8 | 2017-12-04 | ||
| EP17382832 | 2017-12-04 | ||
| PCT/EP2018/082999 WO2019110416A1 (en) | 2017-12-04 | 2018-11-29 | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505554A JP2021505554A (ja) | 2021-02-18 |
| JP2021505554A5 true JP2021505554A5 (https=) | 2022-01-06 |
| JP7846501B2 JP7846501B2 (ja) | 2026-04-15 |
Family
ID=60673756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529733A Active JP7846501B2 (ja) | 2017-12-04 | 2018-11-29 | 眼の後部の疾患を治療するためのドベシル酸を含む眼科用局所組成物 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20200390729A1 (https=) |
| EP (1) | EP3720428B1 (https=) |
| JP (1) | JP7846501B2 (https=) |
| KR (1) | KR102756155B1 (https=) |
| CN (1) | CN111542316A (https=) |
| AU (1) | AU2018378981B2 (https=) |
| BR (1) | BR112020011160A2 (https=) |
| CA (1) | CA3083835A1 (https=) |
| CL (1) | CL2020001426A1 (https=) |
| DK (1) | DK3720428T3 (https=) |
| ES (1) | ES2941036T3 (https=) |
| FI (1) | FI3720428T3 (https=) |
| HR (1) | HRP20230319T1 (https=) |
| HU (1) | HUE061852T2 (https=) |
| MA (1) | MA50991B1 (https=) |
| MX (1) | MX2020005809A (https=) |
| MY (1) | MY205498A (https=) |
| PH (1) | PH12020550722A1 (https=) |
| PL (1) | PL3720428T3 (https=) |
| PT (1) | PT3720428T (https=) |
| SG (1) | SG11202004940VA (https=) |
| SI (1) | SI3720428T1 (https=) |
| WO (1) | WO2019110416A1 (https=) |
| ZA (1) | ZA202003944B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202300017430A1 (it) * | 2023-08-22 | 2025-02-22 | Service Biotech srl | Soluzione oftalmica in forma di collirio contenente una isoforma umana ricombinante di manganese superossido dismutasi (rmnsod) per la cura di patologie dell’occhio |
| CN117257963B (zh) * | 2023-11-02 | 2024-07-16 | 广州准优生物科技有限公司 | 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途 |
| CN117643573B (zh) * | 2024-01-29 | 2024-05-03 | 天津医科大学眼科医院 | 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE51421B1 (en) * | 1980-08-01 | 1986-12-24 | Smith & Nephew Ass | Ophthalmic compositions containing triamterene |
| US9198886B2 (en) * | 2006-08-16 | 2015-12-01 | Pedro Cuevas Sánchez | Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| JP2015500213A (ja) | 2011-11-30 | 2015-01-05 | ザイジェン インフラメーション リミテッド | 眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用 |
| EP2777699B1 (en) | 2012-02-02 | 2017-03-29 | Invesfovea S.L. | Diethylamine-2,5-dihydroxybenzenesulfonate for the treatment of age-related macular degeneration |
| CA2866405A1 (en) | 2012-03-05 | 2013-09-12 | Wayne State University | Identification of channelopsin-2 (chop2) mutations and methods of use |
| RU2014140116A (ru) | 2012-04-24 | 2016-06-10 | Тромбодженикс Н.В. | Антитела против pdgf-c |
| EP2875811A1 (en) | 2013-11-26 | 2015-05-27 | Luis Antonio Outeirino Miguez | Use of dobesilate for treating ocular haemorrhages |
-
2018
- 2018-11-29 DK DK18811023.3T patent/DK3720428T3/da active
- 2018-11-29 EP EP18811023.3A patent/EP3720428B1/en active Active
- 2018-11-29 MA MA50991A patent/MA50991B1/fr unknown
- 2018-11-29 HR HRP20230319TT patent/HRP20230319T1/hr unknown
- 2018-11-29 MY MYPI2020002628A patent/MY205498A/en unknown
- 2018-11-29 ES ES18811023T patent/ES2941036T3/es active Active
- 2018-11-29 FI FIEP18811023.3T patent/FI3720428T3/fi active
- 2018-11-29 PT PT188110233T patent/PT3720428T/pt unknown
- 2018-11-29 PL PL18811023.3T patent/PL3720428T3/pl unknown
- 2018-11-29 SG SG11202004940VA patent/SG11202004940VA/en unknown
- 2018-11-29 CN CN201880082202.1A patent/CN111542316A/zh active Pending
- 2018-11-29 KR KR1020207018983A patent/KR102756155B1/ko active Active
- 2018-11-29 US US16/770,027 patent/US20200390729A1/en active Pending
- 2018-11-29 HU HUE18811023A patent/HUE061852T2/hu unknown
- 2018-11-29 JP JP2020529733A patent/JP7846501B2/ja active Active
- 2018-11-29 WO PCT/EP2018/082999 patent/WO2019110416A1/en not_active Ceased
- 2018-11-29 AU AU2018378981A patent/AU2018378981B2/en active Active
- 2018-11-29 CA CA3083835A patent/CA3083835A1/en active Pending
- 2018-11-29 BR BR112020011160-0A patent/BR112020011160A2/pt unknown
- 2018-11-29 SI SI201830869T patent/SI3720428T1/sl unknown
- 2018-11-29 MX MX2020005809A patent/MX2020005809A/es unknown
-
2020
- 2020-05-27 PH PH12020550722A patent/PH12020550722A1/en unknown
- 2020-05-28 CL CL2020001426A patent/CL2020001426A1/es unknown
- 2020-06-29 ZA ZA2020/03944A patent/ZA202003944B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5421272B2 (ja) | 眼病治療のための組成物及び方法 | |
| US20200323685A1 (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| JP2021505554A5 (https=) | ||
| JP2008538215A5 (https=) | ||
| CN111372576A (zh) | 用于治疗眼部病症的组合物和方法 | |
| US20140025022A1 (en) | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension | |
| JP2021519753A5 (https=) | ||
| US20060111388A1 (en) | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye | |
| HRP20230319T1 (hr) | Očni topikalni pripravak koji sadrži dobesilnu kiselinu, namijenjen liječenju bolesti stražnjeg segmenta oka | |
| WO2008124828A1 (en) | Methods for treating vascular disruption disorders | |
| CN111315369A (zh) | 用于治疗眼部病症和皮肤疾病的化合物、组合物和方法 | |
| Bagnis et al. | Antiglaucoma drugs: The role of preservative-free formulations | |
| JP2021534217A5 (https=) | ||
| CN104758249A (zh) | 用于眼药物递送的稳定的脂质体制剂 | |
| Omoti | A review of the choice of therapy in primary open angle glaucoma | |
| ES2624446T3 (es) | Compuestos donantes de óxido nítrico a base de quinona para uso oftalmológico | |
| GB2432526A (en) | Use of ifenprodil for the treatment of ophthalmic diseases | |
| JP2012505928A5 (https=) | ||
| RU2642731C1 (ru) | Способ хирургического лечения открытоугольной глаукомы у пациентов с артифакией | |
| RU2607291C1 (ru) | Способ лечения первичной глаукомы у больных с сопутствующей артериальной гипертензией | |
| Balasubramanian | ADVANCEMENTS IN GLAUCOMA TREATMENT: A REVIEW OF CURRENT AND EMERGING MODALITIES | |
| JP2009517375A (ja) | 眼の疾患の治療 | |
| JP2025526363A (ja) | 緑内障及び関連する状態の治療のための方法及び組成物 | |
| EP2875811A1 (en) | Use of dobesilate for treating ocular haemorrhages | |
| Yadgari et al. | Elevated intraocular pressure after pars plana vitrectomy: a review |